Impact of body mass Index on anti-müllerian hormone levels in infertile women with and without polycystic ovary syndrome

Background: Polycystic ovarian disease (PCOD) is a common endocrine disorder among infertile women and is associated with increased body mass index (BMI) and elevated serum anti-Müllerian hormone (AMH) levels. However, the relationship between BMI and AMH varies depending on the presence of PCOD. Objective: To assess the association between BMI and AMH in infertile women with and without PCOD. Materials and Methods: A cross-sectional study was conducted on 120 infertile women aged 20-35 years, divided into two groups: PCOD (n=60) and non-PCOD (n=60). BMI and serum AMH levels were measured, and statistical correlations were analyzed. Results: Women with PCOD had significantly higher AMH (5.4±2.3 ng/mL) than those without PCOD (2.1±1.2 ng/mL, p